Arreola-Valdez SA

Idioma: Español
Referencias bibliográficas: 33
Paginas: 17-26
Archivo PDF: 277.48 Kb.

RESUMEN

La incidencia del cncer ha aumentado con el transcurso de los aos, al igual que los avances cientficos y tecnolgicos para poder estudiarlo. Por lo anterior, se ha logrado una mejor deteccin y caracterizacin de sndromes paraneoplsicos, manifestaciones clnicas de malignidad ocasionadas por el tumor, las metstasis o el tratamiento (particularmente la inmunoterapia). En esta revisin se resaltan los sndromes ms representativos de cada sistema, destacando el carcinoma pulmonar de clulas pequeas y los tumores ginecolgicos que se han relacionado con la gran mayora de estos sndromes, algunos ejemplos a enfatizar son el sndrome de Lambert-Eaton, la encefalitis autoinmune y el sndrome carcinoide.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Amber KT, Valdebran M, Grando SA. Paraneoplastic autoimmune multiorgan syndrome (PAMS): Beyond the single phenotype of paraneoplastic pemphigus. Autoimmun Rev. 2018; 17 (10): 1002-1010.

2. Ashour AA, Verschraegen CF, Kudelka AP, Kavanagh JJ. Paraneoplastic syndromes of gynecologic neoplasms. J Clin Oncol. 1997; 15 (3): 1272-1282.

3. Lpez-Riverol O, Camacho-Limas CP, Gerson-Cwilich R. Sndromes paraneoplsicos. Diagnstico y tratamiento. Rev Hosp Jua Mex. 2016; 83 (1-2): 31-40.

4. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144 (5): 646-674.

5. Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016; 23 (1): 27-47.

6. Martin-Moutot N, de Haro L, Seagar M. Dosage and specificity of anti-calcium channel antibodies in Lambert-Eaton myasthenic syndrome. Rev Neurol (Paris). 2004; 160 (5 Pt 2): S28-S34.

7. Rosenfeld MR, Dalmau J. Paraneoplastic neurologic syndromes. Neurol Clin. 2018; 36 (3): 675-685.

8. Ruelle L, Bentea G, Sideris S, El Koulali M, Holbrechts S, Lafitte JJ et al. Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature Part 4: Neurological paraneoplastic syndromes, involving the peripheral nervous system and the neuromuscular junction and muscles. Lung Cancer. 2017; 111: 150-163.

9. Bentea G, Sculier C, Grigoriu B, Meert AP, Durieux V, Berghmans T et al. Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 3: Neurological paraneoplastic syndromes, involving the central nervous system. Lung Cancer. 2017; 106: 83-92.

10. Sculier C, Bentea G, Ruelle L, Grigoriu B, Coureau M, Gorham J et al. Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 5: Neurological auto-antibodies, discussion, flow chart, conclusions. Lung Cancer. 2017; 111: 164-175.

11. Armangue T, Leypoldt F, Mlaga I, Raspall-Chaure M, Marti I, Nichter C et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol. 2014; 75 (2): 317-3123.

12. Pujol JL, Di Mercurio JP, Carlander B. Anti-Hu antibodies: a remarkable immulogical phenotype for several paraneoplastic syndromes. Rev Mal Respir. 2013; 30 (7): 521-523.

13. Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol. 2004; 56 (5): 715-719.

14. Saleh, D, Tanner LS. Vohwinkel syndrome. In: Abai B, Abu-Gosh A, Acharya AB, Acharya U, Adigun R, Aeby TC et al, editors. Stat pearls. Treasure Island (FL): StatPearls Publishing; 2018.

15. Dalmau J, Graus F, Villarejo A, Posner JB, Blumenthal D, Thiessen B et al. Clinical analysis of anti-Ma2-associated encephalitis. Brain. 2004; 127 (Pt 8): 1831-1844.

16. Liao YJ, Safa P, Chen YR, Sobel RA, Boyden ES, Tsien RW. Anti-Ca2+ channel antibody attenuates Ca2+ currents and mimics cerebellar ataxia in vivo. Proc Natl Acad Sci U S A. 2008; 105 (7): 2705-2710.

17. Kumar V, Abbas A, Aster J. Robbins & Cotran pathologic basis of disease. 9th edition. Canada: Elsevier Saunders; 2015.

18. Viau M, Renaud MC, Grgoire J, Sebastianelli A, Plante M. Paraneoplastic syndromes associated with gynecological cancers: A systematic review. Gynecol Oncol. 2017; 146 (3): 661-671.

19. Wang M, Wang X, Chen T, Zhao J, Peng Y, Chen X et al. Erosive oral lichen planus as a sign of paraneoplastic pemphigus. J Dermatol. 2016; 43 (8): 983.

20. Kallini JR, Sadeghani K, Khachemoune A. Paraneoplastic palmoplantar keratoderma secondary to metastatic uterine adenocarcinoma. Cutis. 2017; 99 (3): E32-E35.

21. Martn-Jimnez ML, Palacios-Garca N, Salas-Antn C, Armengod-Grao L, Aller-Pardo J. Feocromocitoma productor de corticotropoina. Endocrinol Nutr. 2013; 60: 418-420.

22. DiIenno N, Han E, Maitland C, Kansara V. Hypoglycemia in renal cell carcinoma: a rare paraneoplastic syndrome. Urology. 2019; 124: 10-13.

23. van der Lely AJ, de Herder WW. Carcinoid syndrome: diagnosis and medical management. Arq Bras Endocrinol Metabol. 2005; 49 (5): 850-860.

24. Liebman HA. Thrombocytopenia in cancer patients. Thromb Res. 2014; 133 Suppl 2: S63-S69.

25. Chang H, Kuo MC, Shih LY, Dunn P, Wang PN, Wu JH et al. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia. Eur J Haematol. 2012; 88 (4): 321-328.

26. Wilson FP, Berns JS. Tumor lysis syndrome: new challenges and recent advances. Adv Chronic Kidney Dis. 2014; 21 (1): 18-26.

27. Delgado MD, Cestari JJ, Lestn-Tauret AH, Alemano G. Sndrome de lisis tumoral. Revisin bibliogrfica a 90 aos de su descripcin. Rev Nefrol Dial Traspl. 2018; 38 (2): 148-159.

28. Instituto Nacional de Cancerologa. Datos epidemiolgicos del cncer de pulmn. [Acceso 01 de noviembre de 2018]. Obtenido de: http://cancerdepulmon.com.mx/#datos-epidemiol%C3%B3gicos

29. Villalobos-Mora C, Mora-Hernndez GA. Tumor de Pancoast. Rev Med Cos Cen. 2015; 72 (614): 153-157.

30. Simonsen M, Miyabe MM, Ouki HT, Galvo ACR, Leite D, Murayama BAR et al. Myasthenia as a paraneoplastic manifestation of ovarian Cancer. Gynecol Oncol Rep. 2018; 25: 35-36.

31. Zaborowski MP, Spaczynski M, Nowak-Markwitz E, Michalak S. Paraneoplastic neurological syndromes associated with ovarian tumors. J Cancer Res Clin Oncol. 2015; 141 (1): 99-108.

32. Gomes-Ferreira M, Lapresa-Alcalde V, Garca-Snchez MH, Hernndez-Hernndez L, Doyague-Snchez MJ. Successful treatment of anti-NMDA receptor encephalitis with early teratoma removal and plasmapheresis: A case report. Medicine (Baltimore). 2018; 97 (31): e11325.

33. Murphy N, Shen J, Shih A, Liew A, Khalili H, Yaskiv O et al. Paraneoplastic syndrome secondary to treatment emergent neuroendocrine tumor in metastatic castration-resistant prostate cancer: a unique case. Clin Genitourin Cancer. 2019; 17 (1): e56-e60.